Literature DB >> 1673047

Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA vWD mutation (IIe865 to Thr).

M C Iannuzzi1, N Hidaka, M Boehnke, M E Bruck, W T Hanna, F S Collins, D Ginsburg.   

Abstract

Reports of families with members affected with both von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia (HHT) suggest a possible relationship between these two disorders. vWD, the most common inherited bleeding disorder in humans, is due to either a quantitative or qualitative defect in von Willebrand factor (vWF). The gene for vWF has been cloned and mapped to chromosome 12 (12p12----12pter). HHT, an uncommon inherited bleeding disorder, is characterized by malformed, dilated, fragile blood vessels. The chromosomal location of the gene for HHT is unknown. We studied two families by RFLP analysis to determine whether there is a molecular basis for the association of vWD and HHT. Family A is affected with both type IIA vWD and HHT; family B is affected with HHT alone. Linkage of HHT to the vWF gene was not detected, and vWF was ruled out as a candidate gene for HHT. The vWF gene was found to be tightly linked to type IIA vWD in family A (lod score 3.61 at recombination fraction .00). By PCR and DNA sequence analysis of vWF exon 28, a single T----C transition resulting in the substitution of Thr for Ile865 was identified. This substitution is located immediately adjacent to two previously identified type IIA vWD mutations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1673047      PMCID: PMC1682950     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  33 in total

1.  Hereditary hemorrhagic telangiectasia and pulmonary arteriovenous fistula: survey of a large family.

Authors:  C H HODGSON; H B BURCHELL; C A GOOD; O T CLAGETT
Journal:  N Engl J Med       Date:  1959-09-24       Impact factor: 91.245

2.  Factor VIII/von Willebrand factor. Structure and function.

Authors:  T S Zimmerman
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

3.  Rapid, nonradioactive detection of mutations in the human genome by allele-specific amplification.

Authors:  H Okayama; D T Curiel; M L Brantly; M D Holmes; R G Crystal
Journal:  J Lab Clin Med       Date:  1989-08

4.  Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.

Authors:  D Ginsburg; B A Konkle; J C Gill; R R Montgomery; P L Bockenstedt; T A Johnson; A Y Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

Review 5.  Von Willebrand disease.

Authors:  L Holmberg; I M Nilsson
Journal:  Clin Haematol       Date:  1985-06

6.  Persistent gastrointestinal bleeding due to angiodysplasia of the gut in von Willebrand's disease.

Authors:  D M Ramsay; T A Buist; D A Macleod; R C Heading
Journal:  Lancet       Date:  1976-08-07       Impact factor: 79.321

7.  Epidemiological investigation of the prevalence of von Willebrand's disease.

Authors:  F Rodeghiero; G Castaman; E Dini
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

8.  von Willebrand disease investigated by two novel RFLPs.

Authors:  F Bernardi; S Guerra; P Patracchini; S Volinia; D Buzzoni; G Ballerini; A Casonato; G Marchetti
Journal:  Br J Haematol       Date:  1988-02       Impact factor: 6.998

9.  Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene.

Authors:  C L Verweij; R Quadt; E Briët; K Dubbeldam; G B van Ommen; H Pannekoek
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

10.  Epitope mapping of the von Willebrand factor subunit distinguishes fragments present in normal and type IIA von Willebrand disease from those generated by plasmin.

Authors:  S D Berkowitz; J Dent; J Roberts; Y Fujimura; E F Plow; K Titani; Z M Ruggeri; T S Zimmerman
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

View more
  5 in total

1.  Germ-line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of von Willebrand factor, causing type IIB von Willebrand disease.

Authors:  E W Murray; A R Giles; D Lillicrap
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

Review 2.  Molecular genetics of type 2 von Willebrand disease.

Authors:  Edith Fressinaud; Claudine Mazurier; Dominique Meyer
Journal:  Int J Hematol       Date:  2002-01       Impact factor: 2.490

3.  Linkage of hereditary haemorrhagic telangiectasia to chromosome 9q34 and evidence for locus heterogeneity.

Authors:  P Heutink; T Haitjema; G J Breedveld; B Janssen; L A Sandkuijl; C J Bontekoe; C J Westerman; B A Oostra
Journal:  J Med Genet       Date:  1994-12       Impact factor: 6.318

Review 4.  Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective.

Authors:  Athena Kritharis; Hanny Al-Samkari; David J Kuter
Journal:  Haematologica       Date:  2018-05-24       Impact factor: 9.941

5.  Structural basis of type 2A von Willebrand disease investigated by molecular dynamics simulations and experiments.

Authors:  Gianluca Interlandi; Minhua Ling; An Yue Tu; Dominic W Chung; Wendy E Thomas
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.